SOPHiA GENETICS (SOPH)
(Delayed Data from NSDQ)
$3.23 USD
+0.06 (1.89%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $3.23 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SOPH 3.23 +0.06(1.89%)
Will SOPH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SOPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SOPH
Strategic Partnerships Power Tempus AI's Healthcare Expansion
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
SOPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
Other News for SOPH
SOPH forms NR7 on September 15
NR7 appears for SOPH after 2.5% move
Is SOPH setting up for a drop? Fell Below 200 Day Moving Average shows up after declining 3.32%
Crossed Above 200 Day Moving Average appears for SOPH after 1.53% move
Fell Below 200 Day Moving Average appears for SOPH after 1.81% move